Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
pubmed:
14
3
2019
medline:
17
6
2020
entrez:
14
3
2019
Statut:
ppublish
Résumé
Limited empirical research has examined the extent to which cohort-level prevalence of substance use is associated with the onset of drug use and transitioning into greater involvement with drug use. To use cross-national data to examine time-space variation in cohort-level drug use to assess its associations with onset and transitions across stages of drug use, abuse, dependence, and remission. The World Health Organization World Mental Health Surveys carried out cross-sectional general population surveys in 25 countries using a consistent research protocol and assessment instrument. Adults from representative household samples were interviewed face-to-face in the community in relation to drug use disorders. The surveys were conducted between 2001 and 2015. Data analysis was performed from July 2017 to July 2018. Data on timing of onset of lifetime drug use, DSM-IV drug use disorders, and remission from these disorders was assessed using the Composite International Diagnostic Interview. Associations of cohort-level alcohol prevalence and drug use prevalence were examined as factors associated with these transitions. Among the 90 027 respondents (48.1% [SE, 0.2%] men; mean [SE] age, 42.1 [0.1] years), 1 in 4 (24.8% [SE, 0.2%]) reported either illicit drug use or extramedical use of prescription drugs at some point in their lifetime, but with substantial time-space variation in this prevalence. Among users, 9.1% (SE, 0.2%) met lifetime criteria for abuse, and 5.0% (SE, 0.2%) met criteria for dependence. Individuals who used 2 or more drugs had an increased risk of both abuse (odds ratio, 5.17 [95% CI, 4.66-5.73]; P < .001) and dependence (odds ratio, 5.99 [95% CI, 5.02-7.16]; P < .001) and reduced probability of remission from abuse (odds ratio, 0.86 [95% CI, 0.76-0.98]; P = .02). Birth cohort prevalence of drug use was also significantly associated with both initiation and illicit drug use transitions; for example, after controlling for individuals' experience of substance use and demographics, for each additional 10% of an individual's cohort using alcohol, a person's odds of initiating drug use increased by 28% (odds ratio, 1.28 [95% CI, 1.26-1.31]). Each 10% increase in a cohort's use of drug increased individual risk by 12% (1.12 [95% CI, 1.11-1.14]). Birth cohort substance use is associated with drug use involvement beyond the outcomes of individual histories of alcohol and other drug use. This has important implications for understanding pathways into and out of problematic drug use.
Identifiants
pubmed: 30865282
pii: 2727386
doi: 10.1001/jamapsychiatry.2019.0163
pmc: PMC6583659
mid: NIHMS1037297
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
708-720Subventions
Organisme : NIDA NIH HHS
ID : R01 DA044170
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH059575
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Subst Use Misuse. 2000 May-Jun;35(6-8):925-48
pubmed: 10847217
Alcohol Clin Exp Res. 2003 Jan;27(1):93-9
pubmed: 12544012
Br J Psychiatry. 2003 Apr;182:330-6
pubmed: 12668409
Biol Psychiatry. 2004 Jan 1;55(1):69-76
pubmed: 14706427
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Arch Gen Psychiatry. 2004 Sep;61(9):891-6
pubmed: 15351767
Int J Methods Psychiatr Res. 2005;14(3):119-29
pubmed: 16389888
Addict Behav. 2006 Jun;31(6):962-83
pubmed: 16677774
Int J Methods Psychiatr Res. 2006;15(4):167-80
pubmed: 17266013
Alcohol Clin Exp Res. 2008 May;32(5):763-70
pubmed: 18336633
Drug Alcohol Depend. 2009 Jan 1;99(1-3):68-78
pubmed: 18768267
Addiction. 2009 Jan;104(1):27-37
pubmed: 19133886
Addiction. 2009 Aug;104(8):1313-23
pubmed: 19438840
Compr Psychiatry. 2009 Jul-Aug;50(4):299-306
pubmed: 19486727
J Stud Alcohol Drugs. 2010 Sep;71(5):695-703
pubmed: 20731974
Drug Alcohol Depend. 2011 May 1;115(1-2):120-30
pubmed: 21145178
Alcohol Alcohol. 2011 May-Jun;46(3):324-32
pubmed: 21414952
Subst Use Misuse. 2011;46(9):1169-78
pubmed: 21417555
Addiction. 2011 Oct;106(10):1790-800
pubmed: 21545669
J Child Adolesc Subst Abuse. 2012 Sep 1;21(4):333-348
pubmed: 23284228
Am J Psychiatry. 2013 Jun;170(6):660-70
pubmed: 23511653
Am J Drug Alcohol Abuse. 2013 May;39(3):168-79
pubmed: 23721532
Alcohol Alcohol. 2014 Jan-Feb;49(1):103-8
pubmed: 23904251
Drug Alcohol Rev. 2014 Sep;33(5):555-64
pubmed: 25186194
Lancet Psychiatry. 2016 Mar;3(3):251-64
pubmed: 26905480
Lancet Psychiatry. 2016 Mar;3(3):265-79
pubmed: 26905482
Int J Methods Psychiatr Res. 2017 Sep;26(3):
pubmed: 28211594
Drug Alcohol Rev. 2018 May;37(4):546-556
pubmed: 29505682
Drug Alcohol Depend. 2018 Oct 1;191:145-151
pubmed: 30107320
J Nerv Ment Dis. 1988 Dec;176(12):719-25
pubmed: 3199107
Am J Public Health. 1988 Oct;78(10):1315-21
pubmed: 3421387
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
pubmed: 8279933
J Subst Abuse. 1996;8(2):195-210
pubmed: 8880660
J Stud Alcohol. 1997 Sep;58(5):464-73
pubmed: 9273910